Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921722000> ?p ?o ?g. }
- W2921722000 endingPage "654" @default.
- W2921722000 startingPage "644" @default.
- W2921722000 abstract "Abstract Introduction We investigated relations between amyloid‐β (Aβ) status, apolipoprotein E ( APOE ) ε4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng), neurofilament light (NFL), YKL‐40, and total tau (T‐tau). Methods We included 770 individuals with normal cognition, mild cognitive impairment, and Alzheimer's disease (AD)‐type dementia from the EMIF‐AD Multimodal Biomarker Discovery study. We tested the association of Ng, NFL, YKL‐40, and T‐tau with Aβ status (Aβ− vs. Aβ+), clinical diagnosis APOE ε4 carriership, baseline cognition, and change in cognition. Results Ng and T‐tau distinguished between Aβ+ from Aβ− individuals in each clinical group, whereas NFL and YKL‐40 were associated with Aβ+ in nondemented individuals only. APOE ε4 carriership did not influence NFL, Ng, and YKL‐40 in Aβ+ individuals. NFL was the best predictor of cognitive decline in Aβ+ individuals across the cognitive spectrum. Discussion Axonal degeneration, synaptic dysfunction, astroglial activation, and altered tau metabolism are involved already in preclinical AD. NFL may be a useful prognostic marker." @default.
- W2921722000 created "2019-03-22" @default.
- W2921722000 creator A5002493210 @default.
- W2921722000 creator A5004136948 @default.
- W2921722000 creator A5008906120 @default.
- W2921722000 creator A5011803247 @default.
- W2921722000 creator A5012378779 @default.
- W2921722000 creator A5015407411 @default.
- W2921722000 creator A5018434240 @default.
- W2921722000 creator A5020077464 @default.
- W2921722000 creator A5020936422 @default.
- W2921722000 creator A5022295403 @default.
- W2921722000 creator A5025870220 @default.
- W2921722000 creator A5041038663 @default.
- W2921722000 creator A5045907715 @default.
- W2921722000 creator A5050002274 @default.
- W2921722000 creator A5050497539 @default.
- W2921722000 creator A5054596281 @default.
- W2921722000 creator A5057473716 @default.
- W2921722000 creator A5062687221 @default.
- W2921722000 creator A5062777125 @default.
- W2921722000 creator A5063533592 @default.
- W2921722000 creator A5064378373 @default.
- W2921722000 creator A5068394264 @default.
- W2921722000 creator A5068903009 @default.
- W2921722000 creator A5071341444 @default.
- W2921722000 creator A5071891017 @default.
- W2921722000 creator A5073065271 @default.
- W2921722000 creator A5075394738 @default.
- W2921722000 creator A5079246880 @default.
- W2921722000 creator A5086914602 @default.
- W2921722000 creator A5088037670 @default.
- W2921722000 creator A5088218106 @default.
- W2921722000 creator A5088896716 @default.
- W2921722000 date "2019-03-07" @default.
- W2921722000 modified "2023-10-18" @default.
- W2921722000 title "Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum" @default.
- W2921722000 cites W1538814448 @default.
- W2921722000 cites W1577433680 @default.
- W2921722000 cites W1619886377 @default.
- W2921722000 cites W1735309556 @default.
- W2921722000 cites W1747781838 @default.
- W2921722000 cites W1847168837 @default.
- W2921722000 cites W1934117767 @default.
- W2921722000 cites W1966720891 @default.
- W2921722000 cites W1974857473 @default.
- W2921722000 cites W1992165389 @default.
- W2921722000 cites W1998440070 @default.
- W2921722000 cites W2008767130 @default.
- W2921722000 cites W2014897304 @default.
- W2921722000 cites W2028436804 @default.
- W2921722000 cites W2036288989 @default.
- W2921722000 cites W2056196309 @default.
- W2921722000 cites W2069440543 @default.
- W2921722000 cites W2085851888 @default.
- W2921722000 cites W2102772375 @default.
- W2921722000 cites W2124361740 @default.
- W2921722000 cites W2125633423 @default.
- W2921722000 cites W2140431554 @default.
- W2921722000 cites W2147576743 @default.
- W2921722000 cites W2147961047 @default.
- W2921722000 cites W2156220037 @default.
- W2921722000 cites W2168334242 @default.
- W2921722000 cites W2257675936 @default.
- W2921722000 cites W2289673868 @default.
- W2921722000 cites W2291435159 @default.
- W2921722000 cites W2511571616 @default.
- W2921722000 cites W2518545320 @default.
- W2921722000 cites W2529926589 @default.
- W2921722000 cites W2560842622 @default.
- W2921722000 cites W2563207743 @default.
- W2921722000 cites W2582524520 @default.
- W2921722000 cites W2584427047 @default.
- W2921722000 cites W2607317708 @default.
- W2921722000 cites W2612977497 @default.
- W2921722000 cites W2615249314 @default.
- W2921722000 cites W2626315527 @default.
- W2921722000 cites W2760858448 @default.
- W2921722000 cites W2817955710 @default.
- W2921722000 cites W52082120 @default.
- W2921722000 doi "https://doi.org/10.1016/j.jalz.2019.01.004" @default.
- W2921722000 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30853464" @default.
- W2921722000 hasPublicationYear "2019" @default.
- W2921722000 type Work @default.
- W2921722000 sameAs 2921722000 @default.
- W2921722000 citedByCount "78" @default.
- W2921722000 countsByYear W29217220002019 @default.
- W2921722000 countsByYear W29217220002020 @default.
- W2921722000 countsByYear W29217220002021 @default.
- W2921722000 countsByYear W29217220002022 @default.
- W2921722000 countsByYear W29217220002023 @default.
- W2921722000 crossrefType "journal-article" @default.
- W2921722000 hasAuthorship W2921722000A5002493210 @default.
- W2921722000 hasAuthorship W2921722000A5004136948 @default.
- W2921722000 hasAuthorship W2921722000A5008906120 @default.
- W2921722000 hasAuthorship W2921722000A5011803247 @default.
- W2921722000 hasAuthorship W2921722000A5012378779 @default.
- W2921722000 hasAuthorship W2921722000A5015407411 @default.